337 related articles for article (PubMed ID: 10810551)
21. [Pseudomyxoma peritonei secondary to a teratoma of the omentum with a mucinous component of borderline malignancy].
Bloget F; Vilain MO; Dabrowski A; Assila C; Cabaret V; Delobelle-Deroide A; Buffin RP
Ann Pathol; 1996; 16(3):182-7. PubMed ID: 8766175
[TBL] [Abstract][Full Text] [Related]
22. Clinical factors and biomarkers in ovarian tumors development.
Vrabie CD; Petrescu A; Waller M; Dina I
Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637
[TBL] [Abstract][Full Text] [Related]
23. Ovarian tumours: a study of 282 cases.
Pilli GS; Suneeta KP; Dhaded AV; Yenni VV
J Indian Med Assoc; 2002 Jul; 100(7):420, 423-4, 447. PubMed ID: 12674165
[TBL] [Abstract][Full Text] [Related]
24. Pathology of borderline (low malignant potential) ovarian tumours.
Seidman JD; Ronnett BM; Kurman RJ
Best Pract Res Clin Obstet Gynaecol; 2002 Aug; 16(4):499-512. PubMed ID: 12413931
[TBL] [Abstract][Full Text] [Related]
25. [The malignant potential of adenofibroma and cystadenofibroma of the ovary and mesovarium. 118 cases including 13 proliferative and 5 carcinomatous].
Randrianjafisamindrakotroka NS; Gasser B; Philippe E
J Gynecol Obstet Biol Reprod (Paris); 1993; 22(1):33-8. PubMed ID: 8463564
[TBL] [Abstract][Full Text] [Related]
26. MRI appearances of borderline ovarian tumours.
Bent CL; Sahdev A; Rockall AG; Singh N; Sohaib SA; Reznek RH
Clin Radiol; 2009 Apr; 64(4):430-8. PubMed ID: 19264189
[TBL] [Abstract][Full Text] [Related]
27. KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants.
Mayr D; Hirschmann A; Löhrs U; Diebold J
Gynecol Oncol; 2006 Dec; 103(3):883-7. PubMed ID: 16806438
[TBL] [Abstract][Full Text] [Related]
28. Ovarian tumors of borderline malignancy (tumors of low malignant potential): a critical appraisal.
Prat J
Adv Anat Pathol; 1999 Sep; 6(5):247-74. PubMed ID: 10472378
[TBL] [Abstract][Full Text] [Related]
29. Results after conservative treatment of serous borderline tumors of the ovary with a micropapillary pattern.
Laurent I; Uzan C; Gouy S; Pautier P; Duvillard P; Morice P
Ann Surg Oncol; 2008 Dec; 15(12):3561-6. PubMed ID: 18820973
[TBL] [Abstract][Full Text] [Related]
30. Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion.
McKenney JK; Balzer BL; Longacre TA
Am J Surg Pathol; 2006 Oct; 30(10):1209-21. PubMed ID: 17001150
[TBL] [Abstract][Full Text] [Related]
31. Borderline tumors of the ovary and peritoneal implants.
Denkert C; Dietel M
Verh Dtsch Ges Pathol; 2005; 89():84-91. PubMed ID: 18035677
[TBL] [Abstract][Full Text] [Related]
32. Management of borderline ovarian tumors.
Tîrnovanu MC; Amancei S; Dumitrescu A; Onofriescu M; Dumitraşcu I
Rev Med Chir Soc Med Nat Iasi; 2012; 116(4):1069-75. PubMed ID: 23700890
[TBL] [Abstract][Full Text] [Related]
33. Pseudomyxoma peritonei. Histologic predictors of patient survival.
Costa MJ
Arch Pathol Lab Med; 1994 Dec; 118(12):1215-9. PubMed ID: 7979917
[TBL] [Abstract][Full Text] [Related]
34. Micropapillary pattern in serous borderline ovarian tumors: does it matter?
Park JY; Kim DY; Kim JH; Kim YM; Kim KR; Kim YT; Nam JH
Gynecol Oncol; 2011 Dec; 123(3):511-6. PubMed ID: 21917305
[TBL] [Abstract][Full Text] [Related]
35. Appendiceal neoplasms and pseudomyxoma peritonei: a population based study.
Smeenk RM; van Velthuysen ML; Verwaal VJ; Zoetmulder FA
Eur J Surg Oncol; 2008 Feb; 34(2):196-201. PubMed ID: 17524597
[TBL] [Abstract][Full Text] [Related]
36. In ovarian neoplasms, BRAF, but not KRAS, mutations are restricted to low-grade serous tumours.
Sieben NL; Macropoulos P; Roemen GM; Kolkman-Uljee SM; Jan Fleuren G; Houmadi R; Diss T; Warren B; Al Adnani M; De Goeij AP; Krausz T; Flanagan AM
J Pathol; 2004 Mar; 202(3):336-40. PubMed ID: 14991899
[TBL] [Abstract][Full Text] [Related]
37. The coexistence of low-grade mucinous neoplasms of the appendix and appendiceal diverticula: a possible role in the pathogenesis of pseudomyxoma peritonei.
Lamps LW; Gray GF; Dilday BR; Washington MK
Mod Pathol; 2000 May; 13(5):495-501. PubMed ID: 10824920
[TBL] [Abstract][Full Text] [Related]
38. Microinvasion links ovarian serous borderline tumor and grade 1 invasive carcinoma.
Hogg R; Scurry J; Kim SN; Friedlander M; Hacker N
Gynecol Oncol; 2007 Jul; 106(1):44-51. PubMed ID: 17467045
[TBL] [Abstract][Full Text] [Related]
39. Borderline epithelial tumors of the ovary.
Hart WR
Mod Pathol; 2005 Feb; 18 Suppl 2():S33-50. PubMed ID: 15761465
[TBL] [Abstract][Full Text] [Related]
40. Serous tumours of low malignant potential (serous borderline tumours): moving toward détente.
Longacre TA; Kempson RL; Hendrickson MR
Histopathology; 2005 Sep; 47(3):315-8. PubMed ID: 16115233
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]